title: Pharmacokinetic and clinical considerations for monitoring asparaginase activity levels during pegaspargase therapy.
authors: Department of Pharmacy Services and Clinical Sciences, University of Michigan Health System and College of Pharmacy, Ann Arbor, Michigan.
authors: Lydia
authors: L
authors: Benitez
authors: Anthony J
authors: AJ
authors: Perissinotti
authors: Maressa
authors: M
authors: Santarossa
authors: Bernard L
authors: BL
authors: Marini
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001215:Asparaginase / Q000378:metabolism*; D006801:Humans; D008297:Male; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents; D011092:Polyethylene Glycols; D001215:Asparaginase